Dr. Terence Hwa's lab at UC San Diego focuses on understanding how bacteria like E. coli and other species respond to their environments by studying their physiology at a quantitative level. The lab uses advanced techniques to measure proteins, genes, and metabolites, allowing them to develop models that explain bacterial behavior and regulation. This research could lead to new ways to manage human pathogens and design effective probiotics.

Dr. Gourisankar Ghosh's lab at UC San Diego studies the IKK complex, which plays a crucial role in regulating inflammation and immune responses. The lab explores how the structural arrangement of this protein complex influences its activation and function, particularly in relation to inflammatory diseases like arthritis. The research aims to develop new therapeutic strategies that could help treat conditions driven by excessive inflammation.

Dr. Yishi Jin's research lab focuses on understanding how synapses and axons develop and maintain their functions throughout the life of an organism. Using the tiny worm C. elegans, the lab investigates the complexities of nerve connections to gain insights into the molecular mechanisms that govern nerve function and repair. This research is crucial for identifying how disruptions can lead to neurological disorders, offering hope for better treatments and understanding of such conditions.

Lisa M Jones's lab at UC San Diego studies proteins in complex environments that better mimic natural cellular conditions. They develop techniques to understand how proteins interact, fold, and aggregate, which can lead to new therapeutic strategies. Their work is particularly focused on improving methods used in mass spectrometry to study protein structure and function in cellular models and in diseases.

Dr. Michael K. Gilson's lab at UC San Diego focuses on innovative drug design through advanced computational methods. The team aims to deepen our understanding of how proteins interact with small molecules, which is crucial for developing new drugs. By mapping thermodynamic properties of proteins and their surroundings, they seek to reveal insights that can improve ligand design and identify potential new drug targets.

Dr. Scott Makeig's lab focuses on advancing the understanding of human brain dynamics through the development of the EEGLab software, which analyzes electroencephalography (EEG) data. This research is crucial for non-invasive brain imaging and studying cognitive processes. The lab integrates various modalities of brain imaging to enhance our interpretation of brain function, benefiting both basic and clinical neuroscience research.

Dr. Prashant Mali's lab at UC San Diego focuses on developing advanced combinatorial genetic screening technologies using CRISPR systems. The aim is to understand how multiple genes interact and how these interactions influence cellular behavior and disease. By creating platforms that allow researchers to perform intricate genetic experiments more efficiently, the lab hopes to contribute to both basic biological understanding and therapeutic development.

Dr. Geoffrey A. Chang's lab at UC San Diego focuses on understanding how nutrients and other important molecules are exchanged between mothers and their infants through transporters in various tissues. They are creating a detailed map called the Mother-infant Metabolite-transporter Atlas (MiMA) to identify which transporters handle specific molecules, and how these interactions affect health and development. This research aims to improve our knowledge of maternal and infant health, potentially leading to advances in nutrition and medical care.

Loren K. Mell's lab focuses on improving treatment options for head and neck cancer patients, especially those who are medically unfit for standard therapies. The lab conducts clinical trials to develop novel therapeutic strategies for older adults and underserved populations, ensuring these groups are well-represented in research. They seek to improve patient outcomes through innovative risk assessment methods and mentorship of emerging investigators in the field.

Dr. Andrew S. Mendiola's lab focuses on understanding how microglia, the immune cells of the brain, contribute to inflammation and damage in multiple sclerosis (MS). The lab investigates the molecular processes that trigger harmful microglial behavior, particularly in relation to the blood-brain barrier and oxidative stress. They aim to discover new therapeutic targets that can help manage MS and prevent further neurodegeneration.

Dr. Pieter C. Dorrestein's lab focuses on how the microorganisms in our gut interact with diet and the human body to influence health and disease. They are working on building a comprehensive database of microbial metabolites, which are small molecules produced by these microbes, to understand their role in conditions like inflammatory bowel disease. The lab combines advanced techniques in metabolomics and data science to discover and characterize these metabolites, aiming to advance nutritional precision medicine.

Dr. Bradley S. Moore's lab at UC San Diego focuses on two major areas: understanding the health risks and benefits associated with seafood consumption through marine contaminants, and developing therapeutic applications for minor cannabinoids found in cannabis. The lab combines expertise from various fields to study both ocean health and innovative cannabinoid therapeutic potential, aiming to improve public health and environmental understanding.

Dr. Gerald Patrick Morris's lab at UC San Diego focuses on improving organ transplantation success by understanding how the immune system reacts to donor organs. They are developing computational tools to predict the risk of rejection based on genetic factors, particularly HLA alleles. This research aims to personalize immunosuppression strategies, making transplant procedures safer and more effective for patients.

Dr. Michael J. Sailor's lab at UC San Diego focuses on creating advanced nanoplatforms that target macrophages to improve treatment for lung infections. They are particularly interested in developing immunotherapies that can enhance the body's ability to fight pathogens like bacteria and viruses, while minimizing harmful inflammatory responses. The lab’s research aims to deliver RNA therapeutics specifically to infected areas in the lungs, which could change how we treat severe infections such as pneumonia.

Dr. Emilie T. Reas's lab focuses on understanding the effects of Alzheimer's disease treatments and COVID-19 related brain injuries. They study how the blood-brain barrier's health affects treatment responses and cognitive outcomes in older adults. Using advanced imaging techniques, the lab aims to identify biomarkers that predict adverse effects from Alzheimer’s therapies and the impact of COVID-19 on brain health, especially concerning sex differences and genetic risk factors.

Dr. Conor Caffrey's lab at UC San Diego focuses on developing new treatments for neurodegenerative diseases, specifically tauopathies like Alzheimer's disease. The lab investigates microtubule-stabilizing compounds to enhance brain health and prevent cognitive decline. Their research includes testing a new compound, CNDR-51997, which has shown promise in improving neuronal function and stability in preclinical models.

Scott M Sternson's lab at UC San Diego focuses on understanding how the brain's neurons influence behavior through their molecular properties and activity. They use innovative imaging techniques to observe how gene expression and calcium dynamics in neurons relate to various behaviors in mice, especially in deep-brain structures. This research aims to unravel the complexities of neuron functions and their impact on feelings like hunger and fear, as well as their implications in health and disease.

Dr. Alexandra C. Newton's lab at UC San Diego focuses on understanding how mutations in a specific enzyme, protein kinase C gamma (PKCg), cause neurodegenerative diseases like Spinocerebellar Ataxia type 14. The research combines various techniques to explore the structural and molecular changes in PKCg that lead to disease. Additionally, her team studies the role of PKC in cancer, aiming to develop therapies that can restore normal signaling in cells when it’s disrupted.

Dr. Aaron F. Carlin's lab at UC San Diego focuses on developing new oral antiviral treatments for RNA viruses, such as coronaviruses and dengue. They create and optimize lipid-based prodrugs that enhance the delivery and effectiveness of antiviral medications, aiming to improve treatment options for infections that pose significant public health risks. The research combines synthetic chemistry and pharmacokinetics to design innovative solutions for a rapidly evolving field.

Dr. Shaochen Chen's lab focuses on developing advanced solutions for treating peripheral nerve injuries in children using innovative engineering techniques. The main project is centered around creating 3D-printed nerve conduits that not only mimic the natural structure of nerves but also incorporate wireless sensors to help monitor recovery in real-time. This research aims to enhance nerve repair outcomes and reduce complications associated with traditional methods, especially in pediatric patients.